Public-domain · open source
OpenJurist
← 287 FSUPP2D 497 - In Re Initial Public Offering Antitrust Litigation

In Re Initial Public Offering Antitrust Litigation’s Empirical Analysis

2003

Citation profile

3
cited by 3 later decisions
1
cited 1 times by the Supreme Court
June 2007
most recently cited

1 federal appellate ·

Relationships

Applies 15 U.S.C. § 1 (§ 1 of the Sherman Antitrust Act) · 15 U.S.C. § 13 (§ 2 of the Clayton Antitrust Act of 1914) · 15 U.S.C. § 771 (CAN-SPAM Act of 2003) · 15 U.S.C. § 77A (§ 1 of the Securities Act of 1933) · 15 U.S.C. § 77B (§ 2 of the Securities Act of 1933) · 15 U.S.C. § 77E (§ 5 of the Securities Act of 1933) · 15 U.S.C. § 77F (§ 6 of the Securities Act of 1933) · 15 U.S.C. § 77G (§ 7 of the Securities Act of 1933)

Relies on Conley v. Gibson · Associated General Contractors of California, Inc. v. California State Council of Carpenters · Standard Oil Company of New Jersey v. United States · Hospital Building Co. v. Trustees of Rex Hospital · United States v. Borden Co.

Most-quoted passages

The sentences later courts lift from this opinion, ranked by how many decisions quote each — the parts of the opinion doing the work. These counts are smaller than the citation total above because most of the 3 citing decisions cite the case generally; a passage count includes only decisions quoting that exact language verbatim.

  1. “[T]he SEC, through application of its broad regulatory authority over the spectrum of conduct related to securities offerings, is empowered to regulate the conduct alleged by ... [pjlaintiffs. It is this sweeping power to regulate that spawns the potential conflict with the antitrust laws that, under Friedman and Stock Exchanges Options, requires a finding of implied immunity.”
    1 later decision quote this exact passage · from the majority
  2. “commitments to purchase other, less attractive securities”
    1 later decision quote this exact passage · from the majority

How this case has been treated — in progress

Whether each later court followed, distinguished, criticized, or overruled this decision. The treatment classification (task #35) runs highest-cited cases first and lights up here as it reaches this one.